Complex Sleep Behaviors Associated with Zolpidem
"Complex sleep behaviors" (also called "complex sleep-related behaviors" or CSBs) refers to potentially dangerous activities performed while not fully awake after taking zolpidem, including sleepwalking, sleep-driving, preparing and eating food, making phone calls, or having sex—with complete amnesia for these events afterward. 1
What These Behaviors Include
Complex sleep behaviors encompass a range of activities that patients perform in a state between sleep and wakefulness:
- Sleepwalking/somnambulism (most common) 2
- Sleep-related eating disorder (SRED) with excessive nighttime food intake and weight gain 2, 3
- Sleep-driving (operating vehicles while not fully conscious) 1
- Other complex activities: making phone calls, cleaning the house, preparing meals, engaging in sexual activity 1, 3
The defining characteristic is complete anterograde amnesia—patients have no memory of these events the next day 1, 2.
Clinical Significance and Dangers
These behaviors carry serious risks:
- Physical injuries: Patients have sustained knife cuts, burns while cooking, and other trauma 3
- Fatal outcomes: The FDA explicitly warns that injuries during CSBs "may result in a fatal outcome" 1
- Legal consequences: Cases have resulted in criminal charges and litigation 4, 5
- Weight gain: SRED can lead to significant weight gain, including extreme obesity in some cases 3
One remarkable case involved a patient who hired a cab to a psychiatric hospital, voluntarily admitted himself, and cooperated with treatment—all while asleep—only regaining awareness the following morning 5.
Incidence and Risk Factors
CSBs occur in approximately 4.7-15.2% of zolpidem users 2, 6, though the exact prevalence varies by study population.
Key Risk Factors:
Dose-dependent effect is the strongest predictor:
- Higher doses (≥10 mg/day) dramatically increase risk (OR = 13.1 in one study) 6
- This dose effect is particularly pronounced in adults under 65 years 7
- Elderly patients may develop CSBs even at lower doses, independent of dose escalation 7
Other significant risk factors:
- Alcohol use (OR = 2.05) 7
- Female sex 6
- Younger age in adults 6
- Not going to sleep immediately after taking the medication 6
- Comorbid conditions: restless legs syndrome (RLS), obstructive sleep apnea (OSA) 8
- Polypharmacy, especially with anticholinergic medications 9
Mechanism and Timing
CSBs can occur:
- After the first dose or any subsequent use 1
- At recommended therapeutic doses 1, 2
- With or without concurrent alcohol or CNS depressants 1
The behaviors result from zolpidem's effects on GABA receptors causing generalized CNS suppression, creating a dissociated state where motor activity occurs without full consciousness or memory formation 10.
Critical Clinical Implications
The FDA mandates immediate discontinuation of zolpidem if a patient experiences any complex sleep behavior 1. This is now a contraindication to further use 1.
Important Caveats:
- Causality is strong: Approximately 88% of reported cases show probable association with zolpidem 2
- Resolution is rapid: All symptoms resolve completely upon zolpidem withdrawal 3
- Recurrence is predictable: Patients may experience multiple similar episodes if zolpidem is continued 5
The 2017 American Academy of Sleep Medicine guidelines acknowledge these risks but note that overall adverse events with zolpidem are "relatively low" and "mild" compared to efficacy benefits 11. However, the FDA has taken a stronger regulatory stance, issuing boxed warnings and making CSBs a contraindication to continued use 1.
Prescribers must counsel all patients about these risks before initiating zolpidem, warn them to discontinue immediately if CSBs occur, and document this discussion 1.